Comparison of time from identification of patients suspected for MDR-TB to initiation of MDR-TB treatment between pre- and post-LPA period - New Delhi, India.

<p>*P-value generated using the Wilcoxon rank sum test; IQR = Inter-quartile range; MDR-TB = Multidrug resistant Tuberculosis;</p>a<p>Solid/liquid culture & Drug Sensitivity Testing (DST).</p>b<p>LPA: Line Probe Assay.</p

Pre-treatment loss to follow-up rate among MDR-TB suspects before and after diagnosis is in the pre-LPA and post-LPA periods at New Delhi, India.

<p>Pre-treatment loss to follow-up rate among MDR-TB suspects before and after diagnosis is in the pre-LPA and post-LPA periods at New Delhi, India.</p

Demographic characteristics of MDR-TB patients according to the method of MDR-TB diagnosis used between 2009–2012 - New Delhi, India.

a<p>Solid culture & Drug Sensitivity Testing (DST),</p>b<p>LPA: Line Probe Assay, MDR-TB: Multidrug resistant Tuberculosis, IQR: Inter-quartile Range.</p

Risk factors for unfavourable response at the end of treatment in new smear positive pulmonary TB patients [N = 1543].

<p>Risk factors for unfavourable response at the end of treatment in new smear positive pulmonary TB patients [N = 1543].</p

Treatment outcome of new smear positive pulmonary TB patients [N = 1565].

<p>Treatment outcome of new smear positive pulmonary TB patients [N = 1565].</p

Study sites for the recurrence of TB among the newly diagnosed sputum positive pulmonary TB patients treated under RNTCP in India.

<p>Study sites for the recurrence of TB among the newly diagnosed sputum positive pulmonary TB patients treated under RNTCP in India.</p

Status at 12 months after Treatment success in new smear positive pulmonary TB patients [N = 1210].

<p>Status at 12 months after Treatment success in new smear positive pulmonary TB patients [N = 1210].</p

Details of TB recurrence in new smear positive pulmonary TB patients [N = 158].

<p>Details of TB recurrence in new smear positive pulmonary TB patients [N = 158].</p

Details on screening, enrolment and follow-up for TB recurrence in new smear positive pulmonary TB patients under RNTCP.

<p>Details on screening, enrolment and follow-up for TB recurrence in new smear positive pulmonary TB patients under RNTCP.</p